NEW FORMULATION Lamictal XR As Add-on Therapy in Epilepsy
Filed Under (Anti Convulsants) by David on 22-01-2010
0
The FDA has approved GlaxoSmith-Kline’s extended-release lamotrigine tablets (generic Lamictal XR) as once-daily, addon therapy for epilepsy patients 13 years of age or older with partial-onset seizures.
During a 19-week study, more patients who took this agent had a significant reduction in seizure frequency compared with patients receiving placebo. The patients in the study had been having seizures that were inadequately controlled with one or two antiepileptic drugs.
